SG Americas Securities’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-125,760
| Closed | -$20.8M | – | 3953 |
|
|
2021
Q2 | $20.8M | Buy |
125,760
+115,532
| +1,130% | +$19.3M | 0.1% | 174 |
|
|
2021
Q1 | $1.57M | Sell |
10,228
-14,578
| -59% | -$1.98M | 0.01% | 1207 |
|
|
2020
Q4 | $3.11M | Buy |
24,806
+8,448
| +52% | +$945K | 0.02% | 799 |
|
|
2020
Q3 | $1.66M | Buy |
16,358
+8,338
| +104% | +$850K | 0.01% | 861 |
|
|
2020
Q2 | $780K | Buy |
8,020
+3,862
| +93% | +$359K | 0.01% | 1660 |
|
|
2020
Q1 | $345K | Sell |
4,158
-4,868
| -54% | -$475K | ﹤0.01% | 2123 |
|
|
2019
Q4 | $1M | Sell |
9,026
-8,788
| -49% | -$904K | 0.01% | 1259 |
|
|
2019
Q3 | $1.77M | Sell |
17,814
-28,022
| -61% | -$2.78M | 0.01% | 1045 |
|
|
2019
Q2 | $4.54M | Buy |
45,836
+27,869
| +155% | +$2.66M | 0.03% | 580 |
|
|
2019
Q1 | $1.98M | Sell |
17,967
-1,304
| -7% | -$136K | 0.02% | 842 |
|
|
2018
Q4 | $1.77M | Buy |
19,271
+7,250
| +60% | +$734K | 0.02% | 965 |
|
|
2018
Q3 | $1.32M | Sell |
12,021
-12,139
| -50% | -$1.26M | 0.01% | 1481 |
|
|
2018
Q2 | $2.26M | Buy |
24,160
+15,626
| +183% | +$1.35M | 0.02% | 855 |
|
|
2018
Q1 | $708K | Buy |
+8,534
| New | +$758K | 0.01% | 1622 |
|
|
2017
Q4 | – | Sell |
-13,542
| Closed | -$1.03M | – | 3801 |
|
|
2017
Q3 | $1.03M | Buy |
13,542
+4,818
| +55% | +$364K | 0.01% | 1237 |
|
|
2017
Q2 | $654K | Sell |
8,724
-1,511
| -15% | -$105K | 0.01% | 1688 |
|
|
2017
Q1 | $668K | Sell |
10,235
-11,703
| -53% | -$689K | 0.01% | 1653 |
|
|
2016
Q4 | $1.21M | Buy |
+21,938
| New | +$1.2M | 0.01% | 1193 |
|
|
2016
Q2 | – | Sell |
-2,537
| Closed | -$108K | – | 3126 |
|
|
2016
Q1 | $108K | Buy |
+2,537
| New | +$107K | ﹤0.01% | 2586 |
|
|
2015
Q3 | – | Sell |
-3,966
| Closed | -$144K | – | 2846 |
|
|
2015
Q2 | $144K | Buy |
+3,966
| New | +$125K | ﹤0.01% | 2155 |
|
Other funds holding PRAH
SG Americas Securities's PRAH Position: Q3 2021 in Review
SG Americas Securities sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 125,760 shares — an estimated $20.8M sold.
SG Americas Securities first reported a position in PRAH in Q2 2015 and held it in 20 quarters. The position peaked at $20.8M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- SG Americas Securities reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- SG Americas Securities sold 125,760 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $20.8M.
- SG Americas Securities first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 20 quarters.
- SG Americas Securities's PRA Health Sciences, Inc. position peaked at $20.8M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on SG Americas Securities's 13F filing for Q3 2021, filed 1 Nov 2021.